feladilimabvopratelimabICOSJTX-2011GSK3359609
…oritized biological activity over toxicity thresholds. Although feladilimab demonstrated favorable safety and robust receptor occupancy, cl…
2articles mentioning drugs
6drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: ICOS ×
ICOS
This drug is selected. Its supporting articles are shown below.
Articles mentioning ICOS
2 articles · page 1 of 1TIGITICOSTIM-3hematopoietic malignanciessolid tumorsanti-PD therapyCancer immunotherapy
…f other ‘checkpoint inhibitors’ targeting molecules like TIM-3, TIGIT, ICOS and others, has largely fallen short, often showing minim…